Search This Blog

Wednesday, April 24, 2013

Novartis delivered solid performance in the first quarter, with eight key regulatory approvals and all divisions contributing to growth

Novartis delivered solid performance in the first quarter, with eight key regulatory approvals and all divisions contributing to growth

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.